Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma
    Journal Article

    Breinig, M.; Caldas-Lopes, E.; Goeppert, B.; Malz, M.; Rieker, R.; Bergmann, F.; Schirmacher, P.; Mayer, M.; Chiosis, G.; Kern, M. A.
    Hepatology (2009)

    Fulltext@MSK | Save
  • Gene therapy for homozygous β -thalassemia. Is it a reality?
    Journal Article

    Boulad, F.; Riviere, I.; Sadelain, M.
    Hemoglobin (2009)

    Fulltext@MSK | Save
  • A new pathway for processing mitochondrial-DNA encoded proteins is essential to mitochondrial energy production in human cancer cells
    Meeting Abstract

    Alvarez, S. N. E.; Gardner, J.; Sheth, A.; Yang, G.; Ouerfelli, O.; Manfredi, G.; Heaney, M. L.; Scheinberg, D. A.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms
    Meeting Abstract

    Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • In vivo antitumor efficacy of purine-scaffold HsP90 inhibitors in basal-like breast cancer (BLBC)
    Meeting Abstract

    Lopes, E. C.; Cerchietti, L.; Robles, A.; Varticovski, L.; Melnick, A.; Chiosis, G.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Hsp90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2008)

    Fulltext@MSK | Save
  • Strategies for therapeutic peptide delivery by mesenchymal stem cells
    Meeting Abstract

    Zhang, X. Y.; To, L.; Reiser, J.; Hemenway, C. S.; Sadelain, M. W.; La Russa, V. F.
    Blood (2008)

    Fulltext@MSK | Save
  • Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T-cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Lack of HLA class I ligands for autologous inhibitory KIR is associated with improved survival following autologous stem cell transplant for children with neuroblastoma
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Hasan, R. S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Blood (2008)

    Fulltext@MSK | Save